Exploring the therapeutic potential of Derris elliptica (Wall.) Benth in Streptozotocin-Induced diabetic Rats: Phytochemical characterization and antidiabetic evaluation

Derris elliptica (Wall.) Benth, a native medicinal plant, has been used to treat diabetes for centuries; however, comprehensive documentation of its bioactive constituents and therapeutic effectiveness is lacking. In this study, we investigated the phytochemical profile and antidiabetic potential of...

Full description

Bibliographic Details
Published in:SAUDI PHARMACEUTICAL JOURNAL
Main Authors: Abd Rahman, Rassheda; Chellammal, Hanish Singh Jayasingh; Shah, Syed Adnan Ali; Zohdi, Rozaini Mohd; Ramachandran, Dhani; Mohsin, Hannis Fadzillah
Format: Article
Language:English
Published: ELSEVIER 2024
Subjects:
Online Access:https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001202934700001
author Abd Rahman
Rassheda; Chellammal
Hanish Singh Jayasingh; Shah
Syed Adnan Ali; Zohdi
Rozaini Mohd; Ramachandran
Dhani; Mohsin
Hannis Fadzillah
spellingShingle Abd Rahman
Rassheda; Chellammal
Hanish Singh Jayasingh; Shah
Syed Adnan Ali; Zohdi
Rozaini Mohd; Ramachandran
Dhani; Mohsin
Hannis Fadzillah
Exploring the therapeutic potential of Derris elliptica (Wall.) Benth in Streptozotocin-Induced diabetic Rats: Phytochemical characterization and antidiabetic evaluation
Pharmacology & Pharmacy
author_facet Abd Rahman
Rassheda; Chellammal
Hanish Singh Jayasingh; Shah
Syed Adnan Ali; Zohdi
Rozaini Mohd; Ramachandran
Dhani; Mohsin
Hannis Fadzillah
author_sort Abd Rahman
spelling Abd Rahman, Rassheda; Chellammal, Hanish Singh Jayasingh; Shah, Syed Adnan Ali; Zohdi, Rozaini Mohd; Ramachandran, Dhani; Mohsin, Hannis Fadzillah
Exploring the therapeutic potential of Derris elliptica (Wall.) Benth in Streptozotocin-Induced diabetic Rats: Phytochemical characterization and antidiabetic evaluation
SAUDI PHARMACEUTICAL JOURNAL
English
Article
Derris elliptica (Wall.) Benth, a native medicinal plant, has been used to treat diabetes for centuries; however, comprehensive documentation of its bioactive constituents and therapeutic effectiveness is lacking. In this study, we investigated the phytochemical profile and antidiabetic potential of D. elliptica methanolic leaf extract (DEME) in diabetic Sprague Dawley rats induced with streptozotocin (STZ). In normal rats, acute oral toxicity evaluations were conducted, and in STZ-induced rats, antidiabetic properties were investigated. 14 days of oral administration of standard glibenclamide and the extract at 200 and 400 mg/kg body weight to diabetic rodents. Assessed parameters included blood glucose levels, alterations in body weight, biochemical markers, and histological analysis of the pancreas, liver, and kidney. Numerous phytoconstituents were uncovered through qualitative phytochemical assays, 1H NMR, and 1H-13C HSQC screening. Quercetin was identified by 1H NMR characterization, and a ceramide analogue compound was isolated and partially characterized by 1H NMR. There were no indications of toxicity or mortality. The treatment with DEME significantly (p < 0.001) decreased body weight and had a remarkable hypoglycemic effect. Both 200 mg/kg and 400 mg/kg extract concentrations decreased total cholesterol levels significantly (p < 0.01 and p < 0.05, respectively). In addition, glibenclamide and the 400 mg/kg dose of extract increased serum insulin levels substantially (p < 0.05) and decreased total bilirubin, lactic acid dehydrogenase, aspartate aminotransferase, and alanine aminotransferase levels. In addition to glibenclamide, treatment with DEME has exhibited cytoprotective effects and increased insulin secretion, thereby exerting a potent antihyperglycemic effect. These results suggest that D. elliptica may have therapeutic potential for the treatment of diabetes mellitus.
ELSEVIER
1319-0164
2213-7475
2024
32
4
10.1016/j.jsps.2024.102016
Pharmacology & Pharmacy
gold
WOS:001202934700001
https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001202934700001
title Exploring the therapeutic potential of Derris elliptica (Wall.) Benth in Streptozotocin-Induced diabetic Rats: Phytochemical characterization and antidiabetic evaluation
title_short Exploring the therapeutic potential of Derris elliptica (Wall.) Benth in Streptozotocin-Induced diabetic Rats: Phytochemical characterization and antidiabetic evaluation
title_full Exploring the therapeutic potential of Derris elliptica (Wall.) Benth in Streptozotocin-Induced diabetic Rats: Phytochemical characterization and antidiabetic evaluation
title_fullStr Exploring the therapeutic potential of Derris elliptica (Wall.) Benth in Streptozotocin-Induced diabetic Rats: Phytochemical characterization and antidiabetic evaluation
title_full_unstemmed Exploring the therapeutic potential of Derris elliptica (Wall.) Benth in Streptozotocin-Induced diabetic Rats: Phytochemical characterization and antidiabetic evaluation
title_sort Exploring the therapeutic potential of Derris elliptica (Wall.) Benth in Streptozotocin-Induced diabetic Rats: Phytochemical characterization and antidiabetic evaluation
container_title SAUDI PHARMACEUTICAL JOURNAL
language English
format Article
description Derris elliptica (Wall.) Benth, a native medicinal plant, has been used to treat diabetes for centuries; however, comprehensive documentation of its bioactive constituents and therapeutic effectiveness is lacking. In this study, we investigated the phytochemical profile and antidiabetic potential of D. elliptica methanolic leaf extract (DEME) in diabetic Sprague Dawley rats induced with streptozotocin (STZ). In normal rats, acute oral toxicity evaluations were conducted, and in STZ-induced rats, antidiabetic properties were investigated. 14 days of oral administration of standard glibenclamide and the extract at 200 and 400 mg/kg body weight to diabetic rodents. Assessed parameters included blood glucose levels, alterations in body weight, biochemical markers, and histological analysis of the pancreas, liver, and kidney. Numerous phytoconstituents were uncovered through qualitative phytochemical assays, 1H NMR, and 1H-13C HSQC screening. Quercetin was identified by 1H NMR characterization, and a ceramide analogue compound was isolated and partially characterized by 1H NMR. There were no indications of toxicity or mortality. The treatment with DEME significantly (p < 0.001) decreased body weight and had a remarkable hypoglycemic effect. Both 200 mg/kg and 400 mg/kg extract concentrations decreased total cholesterol levels significantly (p < 0.01 and p < 0.05, respectively). In addition, glibenclamide and the 400 mg/kg dose of extract increased serum insulin levels substantially (p < 0.05) and decreased total bilirubin, lactic acid dehydrogenase, aspartate aminotransferase, and alanine aminotransferase levels. In addition to glibenclamide, treatment with DEME has exhibited cytoprotective effects and increased insulin secretion, thereby exerting a potent antihyperglycemic effect. These results suggest that D. elliptica may have therapeutic potential for the treatment of diabetes mellitus.
publisher ELSEVIER
issn 1319-0164
2213-7475
publishDate 2024
container_volume 32
container_issue 4
doi_str_mv 10.1016/j.jsps.2024.102016
topic Pharmacology & Pharmacy
topic_facet Pharmacology & Pharmacy
accesstype gold
id WOS:001202934700001
url https://www-webofscience-com.uitm.idm.oclc.org/wos/woscc/full-record/WOS:001202934700001
record_format wos
collection Web of Science (WoS)
_version_ 1809678907487551488